Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14908-8 Rh Type Bld^Newborn Pt Nom &nbsp; &nbsp; ACTIVE Rh [Type] in Blood from Newborn &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 14908-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Rh Bld NB &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Blood; BLOOD BANK; D phenotyping; D typing; Hematology; Heme; NB; New born; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
14909-6 Salicylates SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Salicylates [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14909-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Salicylates SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 2-Hydroxybenzoate; 2-Hydroxybenzoic Acid; DRUG/TOXICOLOGY; Drugs; Level; o-Hydroxybenzoate; o-Hydroxybenzoic Acid; ortho-Hydroxybenzoate; ortho-Hydroxybenzoic Acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Sali; Salicilates; Salicylate; Salicylic acid; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
1491-0 Glucose^30M post 100 g glucose PO MCnc Urine Pt Qn &nbsp; &nbsp; ACTIVE Glucose [Mass/volume] in Urine --30 minutes post 100 g glucose PO &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1491-0 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Glucose 30M p 100 g Glc PO Ur-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 30M p 100 g Glc PO; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 100 g Glc PO; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; 0
14910-4 Serotonin SCnc Ser Pt Qn &nbsp; &nbsp; ACTIVE Serotonin [Moles/volume] in Serum &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14910-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Serotonin Ser-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 5-HT; 5-hydroxytryptamine; 5-hydroxytryptophane; C10H12N2O; Chemistry; Enteramine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14911-2 Sertraline SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Sertraline [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14911-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Sertraline SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Zoloft 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14912-0 Smudge cells/Leukocytes NFr Bld Pt Qn Manual count &nbsp; ACTIVE Smudge cells/Leukocytes in Blood by Manual count &nbsp; NAM DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 14912-0 &nbsp; Manual count &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Smudge Cells NFr Bld Manual &nbsp; &nbsp; &nbsp; Y &nbsp; Basket cells; Blood; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood 2.79 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
14913-8 Testosterone SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Testosterone [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14913-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Testost SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Testo; Testos; Testost 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14914-6 Testosterone.free SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Testosterone Free [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14914-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Testost Free SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; FR; Level; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Testo; Testos; Testost; Testost Free; Testosterone.unconjugated 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
14915-3 Theophylline SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Theophylline [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14915-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Theophylline SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Aminophylline; Biophyllin; Continus; DRUG/TOXICOLOGY; Drugs; Lasma; Level; Nuelin; Phyllocontin; Pl; Plasma; Plsm; Point in time; Pro-vent; QNT; Quan; Quant; Quantitative; Random; Sabidal SR; SerP; SerPl; SerPlas; Serum; Serum or plasma; Slo-Phyllin; Somophyllin; Somophylline; SR; Substance concentration; Theo; Theo-dur; Theolair; Uniphyllin 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14916-1 Thiocyanate SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Thiocyanate [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14916-1 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Thiocyanate SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
14917-9 Thioridazine SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Thioridazine [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14917-9 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Thioridazine SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Level; Mellaril; Novo-ridazine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sonapax; SR; Substance concentration; Thioridazine Hydrochloride; Thioril 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14918-7 Thyroglobulin SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Thyroglobulin [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14918-7 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Thyroglob SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Endocrine; Endocrinology; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tg; Thyglobulin; Thyroglbn; Thyroglob; Tumor marker 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
14919-5 Thyrotropin binding inhibitory immunoglobulins PrThr Ser Pt Ord &nbsp; &nbsp; ACTIVE Thyrotropin binding inhibitory immunoglobulins [Presence] in Serum &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14919-5 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 TSH BII Ser Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Bind; Chemistry; Endocrine; Endocrinology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; TBII; Thyroid stimulating hormone; Thyrotropic hormone; TSH; TSH BII 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
1492-8 Glucose^1.5H post 0.5 g/kg glucose IV MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.5 g/kg glucose IV &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1492-8 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Glucose 1.5h p .5 g/kg Glc IV SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 1 1/2 hours; 1 1/2 HR; 1.5h p .5 g/kg Glc IV; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.34 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; 0
14920-3 Thyroxine.free SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Thyroxine (T4) free [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14920-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 T4 Free SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Endocrine; Endocrinology; FR; FreeT4; FT4; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; T4; T-4; T4 Free; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
14921-1 Thyroxine SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Thyroxine (T4) [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14921-1 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 T4 SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Endocrine; Endocrinology; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14922-9 Toxoplasma gondii Ab.IgA+IgE ACnc Ser Pt Qn IA &nbsp; ACTIVE Toxoplasma gondii IgA+IgE Ab [Units/volume] in Serum by Immunoassay &nbsp; MIN DefinitionDescription &nbsp; &nbsp; kIU/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 14922-9 &nbsp; IA &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 T gondii IgA+IgE Ser IA-aCnc &nbsp; &nbsp; &nbsp; Y &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immune globulin E; Immunoglobulin A; Immunoglobulin E; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; T gondii; Toxo; Toxoplasmosis 2.56 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; k[IU]/L &nbsp; &nbsp; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. 0
14923-7 Toxoplasma gondii Ab ACnc XXX Pt Qn &nbsp; &nbsp; ACTIVE Toxoplasma gondii Ab [Units/volume] in Specimen &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 14923-7 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 T gondii Ab Spec-aCnc &nbsp; &nbsp; &nbsp; Y &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; T gondii; To be specified in another part of the message; Toxo; Toxoplasmosis; Unspecified 2.69 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [arb'U]/mL &nbsp; &nbsp; &nbsp; 0
14924-5 Transfusion reaction Imp Plas/RBC Pt Nar &nbsp; &nbsp; ACTIVE Transfusion reaction [Interpretation] in Plasma or RBC Narrative &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 14924-5 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Transf React PlasRBC-Imp &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLOOD BANK; Erythrocytes; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Pl; Plasma; PlasRBC; Plsm; Point in time; Random; React; Red blood cells; Red blood corpusles; Report; Rxn; Transf React; Tx 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
14925-2 traZODone SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE traZODone [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14925-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 traZODone SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Desyrel; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Trazon; Trialodine 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14926-0 Triazolam SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Triazolam [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14926-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Triazolam SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; APO-TRIAZO; DRUG/TOXICOLOGY; Drugs; Halcion; Level; Novo-triolam; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14927-8 Triglyceride SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Triglyceride [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14927-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Trigl SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Cardio; Cardiology; Chemistry; Heart Disease; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tg; Trig; Trigly; Triglycerides; Triglycrides 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
14928-6 Triiodothyronine.free SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14928-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 T3Free SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Endocrine; Endocrinology; FR; Free T3; FT3; Level; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; T3; T-3; T3Free; thyroid hormone; Total T3; Triodothyrne 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
14929-4 Triiodothyronine.reverse SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Triiodothyronine (T3).reverse [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14929-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 T3Reverse SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Endocrine; Endocrinology; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; REV; Reverse T3; rT3; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; T3; T-3; T3Reverse; thyroid hormone; Total T3; Triodothyrne 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
1493-6 Glucose^1.5H post 0.05-0.15 U insulin/kg IV post 12H CFst MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1493-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Glucose 1.5h p U/kg Ins IV SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 1 1/2 hours; 1 1/2 HR; 1.5h p U/kg Ins IV; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Fast; Fasting; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p 12h fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.34 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; 0
108,248 results found